As we know trials take time and there is a great deal of bureaucracy to go through in such circumstances. An update on progress on process that shows compliance in order to achieve results. If all trials ran totally to a planned timeline that would be extraordinary. So it’s showing as positive for me (yes of course you can disagree) as milestones are being met.
Ann: Phase 2 Stroke Clinical Trial Update, page-4
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
73.5¢ |
Change
-0.010(1.34%) |
Mkt cap ! $94.14M | |||
| Open | High | Low | Value | Volume |
| 74.0¢ | 74.5¢ | 73.5¢ | $6.773K | 9.168K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7626 | 73.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 78.0¢ | 7000 | 1 |
View Market Depth
| Last trade - 15.58pm 05/11/2024 (20 minute delay) ? |
| AGN (ASX) Chart |